Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives every year. CVDs are a group of disorders of the heart and blood vessels and include; coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions.
More than four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age.
What are common symptoms of cardiovascular diseases?
Symptoms of heart attacks and strokes
Often, there are no symptoms of the underlying disease of the blood vessels. A heart attack or stroke may be the first sign of underlying disease. Symptoms of a heart attack include:
- pain or discomfort in the center of the chest; and/or
- pain or discomfort in the arms, the left shoulder, elbows, jaw, or back.
In addition the person may experience difficulty in breathing or shortness of breath; nausea or vomiting; light-headedness or faintness; a cold sweat; and turning pale. Women are more likely than men to have shortness of breath, nausea, vomiting, and back or jaw pain.
The most common symptom of a stroke is sudden weakness of the face, arm, or leg, most often on one side of the body. Other symptoms include sudden onset of:
- numbness of the face, arm, or leg, especially on one side of the body;
- confusion, difficulty speaking or understanding speech;
- difficulty seeing with one or both eyes;
- difficulty walking, dizziness and/or loss of balance or coordination;
- severe headache with no known cause; and/or
- fainting or unconsciousness.
People experiencing these symptoms should seek medical care immediately.
What are the Risk factors for cardiovascular disease?
The most important behavioral risk factors of heart disease and stroke are;
- unhealthy diet
- physical inactivity
- tobacco use
- harmful use of alcohol.
The effects of behavioral risk factors may show up in individuals as raised blood pressure, raised blood glucose, raised blood lipids, and overweight and obesity. These “intermediate risks factors” can be measured in primary care facilities and indicate an increased risk of heart attack, stroke, heart failure and other complications.
The risk of cardiovascular disease have been seen to reduce by;
- Cessation of tobacco use,
- reduction of salt in the diet,
- eating more fruit and vegetables,
- regular physical activity
- avoiding harmful use of alcohol.
Health policies that create conducive environments for making healthy choices affordable and available are essential for motivating people to adopt and sustain healthy behaviours.
Identifying those at highest risk of CVDs and ensuring they receive appropriate treatment can prevent premature deaths. Access to noncommunicable disease medicines and basic health technologies in all primary health care facilities is essential to ensure that those in need receive treatment and counselling.
There are also a number of underlying determinants of CVDs. These are a reflection of the major forces driving social, economic and cultural change – globalization, urbanization and population ageing. Other determinants of CVDs include poverty, stress and hereditary factors.
In addition, drug treatment of hypertension, diabetes and high blood lipids are necessary to reduce cardiovascular risk and prevent heart attacks and strokes among people with these conditions.
WHO supports governments to prevent, manage and monitor CVDs by developing global strategies to reduce the incidence, morbidity and mortality of these diseases. These strategies include reducing risk factors, developing standards of care, enhancing health system capacity to care for patients with CVD, and monitoring disease patterns and trends to inform national and global actions.
The risk factors for CVD include behaviours such as tobacco use, an unhealthy diet, harmful use of alcohol and inadequate physical activity.
They also include physiological factors, including high blood pressure (hypertension), high blood cholesterol and high blood sugar or glucose, which are linked to underlying social determinants and drivers such as ageing, income and urbanization.
What is Rheumatic Heart Disease?
Rheumatic heart disease is caused by damage to the heart valves and heart muscle from the inflammation and scarring caused by rheumatic fever. Rheumatic fever is caused by an abnormal response of the body to infection with streptococcal bacteria, which usually begins as a sore throat or tonsillitis in children.
Rheumatic fever mostly affects children in developing countries, especially where poverty is widespread. Globally, about 2% of deaths from cardiovascular diseases are related to rheumatic heart disease.
Symptoms of Rheumatic heart disease
Symptoms of rheumatic heart disease include: shortness of breath, fatigue, irregular heartbeats, chest pain and fainting.
Symptoms of rheumatic fever include: fever, pain and swelling of the joints, nausea, stomach cramps and vomiting.
Why are cardiovascular diseases a development issue in low- and middle-income countries?
At least three-quarters of the world’s deaths from CVDs occur in low- and middle-income countries. People living in low- and middle-income countries often do not have the benefit of primary health care programmes for early detection and treatment of people with risk factors for CVDs.
People in low- and middle-income countries who suffer from CVDs and other noncommunicable diseases have less access to effective and equitable health care services which respond to their needs. As a result, for many people in these countries detection is often late in the course of the disease and people die at a younger age from CVDs and other noncommunicable diseases, often in their most productive years.
The poorest people in low- and middle-income countries are most affected. At the household level, evidence is emerging that CVDs and other noncommunicable diseases contribute to poverty due to catastrophic health spending and high out-of-pocket expenditure.
At the macro-economic level, CVDs place a heavy burden on the economies of low- and middle-income countries.
How can the burden of cardiovascular diseases be reduced?
The key to cardiovascular disease reduction lies in the inclusion of cardiovascular disease management interventions in universal health coverage packages, although in a high number of countries health systems require significant investment and reorientation to effectively manage CVDs.
Evidence from 18 countries has shown that hypertension programmes can be implemented efficiently and cost-effectively at the primary care level which will ultimately result in reduced coronary heart disease and stroke.
Patients with cardiovascular disease should have access to appropriate technology and medication. Basic medicines that should be available include:
- angiotensin-converting enzyme inhibitors; and
An acute event such as a heart attack or stroke should be promptly managed.
Sometimes, surgical operations are required to treat CVDs. They include:
- coronary artery bypass;
- balloon angioplasty (where a small balloon-like device is threaded through an artery to open the blockage);
- valve repair and replacement;
- heart transplantation; and
- artificial heart operations.
Medical devices are required to treat some CVDs. Such devices include pacemakers, prosthetic valves, and patches for closing holes in the heart.
Some Major Facts to Note
- Cardiovascular diseases (CVDs) are the leading cause of death globally.
- An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
- Over three quarters of CVD deaths take place in low- and middle-income countries.
- Out of the 17 million premature deaths (under the age of 70) due to noncommunicable diseases in 2019, 38% were caused by CVDs.
- Most cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol.
- It is important to detect cardiovascular disease as early as possible so that management with counselling and medicines can begin.
Response from the World Health Organization (WHO)
In 2013, WHO Member States agreed on global mechanisms to reduce the avoidable NCD burden including a “Global action plan for the prevention and control of NCDs 2013-2020”. This Plan aims to reduce the number of premature deaths from NCDs by 25% by 2025 through nine voluntary global targets. Two of the targets directly focus on preventing and controlling CVDs.
Target 6: Reduce global prevalence of raised blood pressure by 25% between 2010 and 2025.
Target 8: At least 50% of eligible people should receive drug therapy and counselling (including glycaemic control) to prevent heart attacks and strokes by 2025.
In addition, target 9 states that there should be 80% availability of the affordable basic technologies and essential medicines, including generics, required to treat major NCDs in both public and private facilities.
Achieving these targets will require significant investment in and strengthening of health systems.
WHO is currently working on increasing the normative guidance available for the management of acute coronary syndrome and stroke which will provide guidance in these important areas.